Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
about
|
my BioMed Central
Health and economic impact of combining metformin with nateglinide to achieve glycemic control: Comparison of the lifetime costs of complications in the U.K.
Ward AJ, Salas M, Caro JJ, Owens D
Cost Eff Resour Alloc
2004 Apr 15,
2
:2
[
Full text
]
[
PubMed
]
[
Related articles
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 1 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
PubMed Central articles that cite the above article:
1.
Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone.
Ristic S, Collober-Maugeais C, Pecher E, Cressier F
Diabet Med
2006 Jul,
23
:757-62
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 1 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of
Springer Science+Business Media
.